MENU

Alnylam Pharmaceuticals (ALNY) Ownership - Who owns Alnylam Pharmaceuticals?

Industry: @Biotechnology

Profile

Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
29.8B
P/E Ratio
N/A
Total Cash
2.37B
Projected Growth
N/A
Total Debt
1.3B
Revenue
2B
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash/Share
18.75
Total Debt/Equity
N/A
Revenue/Share
15.97 USD as % of share price

Fundamentals

ALNY
Capitalization
29.8B
P/E Ratio
N/A
Risk (Beta)
0.29
Dividend Yield
N/A
Total Cash
2.37B
Total Cash/Share
18.75
Total Debt
1.3B
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
15.97%
Revenue
2B
ROE
N/A
Book Value
-219.27M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
-2.64
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.27M
Current Ratio
3.17
Current Revenue Per Employee
235396.67
Dividends Per Share - Security
N/A
EBITDA
-100.79M
Float
N/A
Float - Current
N/A
Gross Income Margin
86.65
Revenue To Assets
-9.20
Shares Held By Institutions
43.4B
Shares Outstanding - Current
126M
Total Liabilities
4.04B
Total Volume MTD
N/A
Value
-1
Gain YTD
23.081
View a ticker or compare two or three
ALNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of therapeutics based on RNA interference

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
675 West Kendall Street
Phone
+1 617 551-8200
Employees
2100
Web
https://www.alnylam.com